Navigation Links
Zeus to Present at Digestive Disease Week in Chicago
Date:5/29/2009

Zeus Research & Development will be one of the presenters at Digestive Disease Week, addressing the topic of invention of new devices in interventional gastroenterology

ORANGEBURG, S.C., May 29 /PRNewswire/ -- Zeus, Inc., a leader in polymer extrusions and material science, announces it has been invited to present at Digestive Disease Week in Chicago on June 1, 2009. Zeus presenters Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specialist Aubrey Sanders will address possible polymer selection for building new and innovative medical devices for interventional procedures in gastrointestinal endoscopy and Natural Orifice Translumenal Endoscopic Surgery (NOTES).

Digestive Disease Week is the world's largest meeting of researchers, physicians, and other professionals in the fields of gastroenterology, endoscopy, gastrointestinal surgery, and hepatology.

When Dr. Naomi Nakao, a prolific inventor of 20 years extended her invitation to Zeus to speak at the conference, she prefaced her invitation as follows: "Being an inventor can be a lonely journey, but Zeus has faithfully stood by me for these many years. Zeus engineers have generously helped me during my research and development of the many prototypes of my inventions. I was gently brought down to earth by Zeus engineers, learning what is, and is not, possible in building my devices. Sharing their company's varied capabilities, I learned from Zeus' engineers that things I did not think possible could be built because of the enormous imagination that Zeus puts into its colossal ensemble of shapes, forms, colors, and sizes of the catheters and other sub-components that it has to offer."

The Zeus presentation will focus primarily on developing industry advancements in polymer science with an emphasis on gastroenterology and endoscopy of the present and future. At the conclusion of the presentation, Dr. Anneaux and Ms. Sanders will participate in an
'/>"/>

SOURCE Zeus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oral VDA CYT997 - Phase I Clinical Trial Presentation at ASCO
2. YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING
3. Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
4. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
5. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
6. Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions
7. Clinical Data on Peregrines Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting
8. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
9. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
10. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
11. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ease is available in German . , Whether it,...: RFID tags (Radio Frequency Identification) are i...They make it possible to label objects or goods an...The appropriate scanner can read and process the d...fixed to goods under production conditions of up t...
(Date:11/24/2009)... The New York investment bank KTA Ca...) has agreed an AU$6.7 mil convertible note privat...e private placement was arranged by KTA Capital as..., New York (PRWEB) Novembe...bank KTA Capital, LLC ("KTA Capital") ha...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced that it has received...in the company,s common stock will be,suspended as...led with the,Securities and Exchange Commission, w...g on Nasdaq, unless the company files an appeal to...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced the approval of all ...Court for the District of Delaware,(the "Bankruptc...tion for,relief under Chapter 11 of the United Sta..., The orders issued by the Bankruptcy Court ...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...., Feb. 17 Sequella, Inc., a clinical-stage bioph...ic potential, today announced the receipt of a Sma...nt from the National Institute of Allergy and Infe...alth (NIH), to fund further preclinical developmen...piperidine drug compound, SQ609. , , The SBIR gr...
...nexpected happens, www.WhatWillYourPlanBe.com offe...er, financial planning and sexual health , , MONT...eal world" expecting that life will go according t...s, finances and relationships. Unfortunately, the... looming problem especially in today,s challenging...
...F, Germany, February 17 , - Sales Grow by 10.7%...proves by 36.6% From EUR1.34 Euro to, EUR1.83...9.5%, - CEO Dr. Axel Herberg: "Following the re...rs itself well equipped to meet the global challen...ntial sales growth of 6% to 7% in, the core b...
Other Biology Technology:Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609 2Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609 3Helping Young Women Succeed in Today's Unpredictable World 2Helping Young Women Succeed in Today's Unpredictable World 3Helping Young Women Succeed in Today's Unpredictable World 4Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009 2Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009 3Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009 4
(Date:11/26/2009)...sive antlers, red deer have been caught in the hun... are much more than decorative. They are lethal we...n Currey, from The University of York, UK, has bee...or over half a century and has become fascinated b...ng-standing collaboration with Tomas Landete-Casti...
(Date:11/26/2009)...tant Staphylococcus Aureus ) and other drug-resis...rature plasma prototype devices have been develope...cidal cocktails. , Two prototype devices have be...althy skin (e.g. hands and feet) in hospitals and ...eat; and another to shoot bacteria-killing agents ...
(Date:11/25/2009)...ad of the Cell Death Research Laboratory in the Un...n awarded the prestigious Johnson & Johnson Focuse...se of brain cell damage in Parkinson,s disease. Th...in support of innovation and excellence in science...earlier this month at an event at the Hyatt Regenc...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 1First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 2First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 3Press Ganey Partners With Health Management Associates 5494 1Press Ganey Partners With Health Management Associates 5494 2NIMBioS hosts 200 undergraduates at national research conference 10362 1
...kin cancer, researchers at the Huntsman Cancer Ins...to inhibit a mutant gene found in up to 30 percent...his gene are important in cell signaling, or commu...s an "oncogene" or cancer-causing gene that has be...ancreas, colon and lung, as well as thyroid cancer...
...on storage molecule in the cell can serve as an ad...ne therapy may use a technique in which non-invasi...ck this molecule. The results of this research, co...titute,s Biological Regulation Department, were pu...n, together with Dr. Batya Cohen of the Institute,...
...icine researchers have discovered how new neurons ... regions of the brain where they can replace old a...ell therapies can be specifically targeted to brai...r by stroke. , Associate Professor Qun-Yong Zhou a...nt of Pharmacology have identified a protein that ...
Other Biology News:Scientists inhibit cancer gene 2Novel live reporting system to track cells 2Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2
... 96-well PCR plate, 0.3ml maximum well volume (whe...ner , Fits all 0.2ml thermal cyclers and ABI PRISM...ll bottom for sample visibility, Highly rigid plat... and Foils, Heat Seals and Flat and Domed Cap Stri...
... use in one-step QRT-PCR reactions, with gene-spec...s offer a quick and simple method for analysing RN...rotocol easy to follow and automation possible. ,T...nted blend of RTases combining the advantages of A...
... to Fc regions of many mammalian immunoglobulins. ...ed as affinity adsorbents to purify immunoglobulin...rum, hybridoma ascites fluids, tissue culture supe...ts are also commonly used to capture immune comple...
Rabbit Anti-Staphylococcus Enterotoxin A Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Biology Products: